UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

Omicron COVID booster cuts hospitalization in over 65s, Israeli study finds

(Reuters) The Omicron-adapted COVID-19 vaccine booster developed by Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE) sharply reduced hospitalizations among older patients, Israeli researchers said on Monday, in some of the first evidence of the jab’s real-world effectiveness.

Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.